---
title: Healthcare
h1: Prove integrity, access and availability where care depends on the system
seoTitle: 'Healthcare Technology Assurance: Integrity and Uptime | Xyvionix'
description: >-
  Continuous assurance for providers, payers and health technology: timed
  clinical system recovery, access to protected health information and data
  integrity.
summary: >-
  In healthcare a lost system, a wrong value or an unreviewed access grant has a
  clinical consequence before it has a financial one. Recovery, access and
  interface integrity are held as current, tested evidence.
lede: >-
  Healthcare technology assurance is the continuing proof that clinical systems
  can be restored inside the time care can tolerate, that access to protected
  health information matches current roles, and that data arrives intact across
  every interface. Each of these is true on the day it is tested and ages from
  that day. Systems are added, staff rotate, interfaces are remapped and
  suppliers change their platforms, so the evidence has to be re-gathered from
  the running estate.
ogQuestion: 'Can integrity, access and uptime be proven where care depends on them?'
kind: primary
cluster: industry
secondary:
  - data
  - cyber
  - reliability
parent: industries
state: assured
audience:
  - CIO
  - CISO
  - Chief Medical Information Officer
  - Chief Data Officer
intent: >-
  Industry: continuous technology assurance for providers, payers and health
  technology
related:
  assurance:
    - data-assurance
    - cyber-exposure-assurance
    - production-reliability-assurance
    - identity-exposure-assurance
    - disaster-recovery-assurance
  useCases:
    - untested-disaster-recovery
    - identity-access-drift
    - security-remediation-backlog
    - data-pipeline-freshness-failure
  technologies:
    - entra-id-exposure-assurance
    - azure-production-reliability
    - databricks-data-assurance
  industries:
    - healthcare-ai-assurance
  insights:
    - disaster-recovery-plan-never-tested
    - how-identity-controls-drift
    - security-findings-vs-verified-closure
evidence:
  - name: Clinical dependency map
    detail: >-
      Each clinical and revenue system with its clinical owner, its downtime
      tolerance, its interfaces and the third parties it relies on, including
      clearinghouses and hosted services outside the organisation.
  - name: Timed restoration results
    detail: >-
      The date, scope and measured duration of each restore, taken from a
      protected copy into a clean environment and confirmed usable by the
      people who operate the system.
  - name: Risk analysis currency record
    detail: >-
      The systems, interfaces and suppliers added or changed since the risk
      analysis was last updated, so that the analysis can be shown to describe
      the estate as it is.
  - name: Access granted and access exercised
    detail: >-
      Who can reach protected health information, by role, compared with who
      has reached it over the measurement window, with emergency access use
      listed and reviewed.
  - name: Interface reconciliation results
    detail: >-
      Counts and content checks between sending and receiving systems for
      orders, results, medication and demographic messages, retained per
      interface and per day.
  - name: Remediation closure record
    detail: >-
      Security findings with the re-test that confirmed each closure, kept
      separately from the ticket status that recorded the work as done.
thresholds:
  - signal: Measured restoration time for each clinical system
    basis: >-
      The period the clinical service can operate safely on downtime
      procedures, set by the clinical owner
    lostWhen: >-
      The last timed restore exceeds the tolerance, or no restore has been
      timed since the system or its dependencies changed
  - signal: Systems holding protected health information that are absent from the risk analysis
    basis: >-
      The expectation that the risk analysis is accurate and thorough for the
      estate as it stands
    lostWhen: >-
      A system, interface or supplier is in production and is not described in
      the current analysis
  - signal: Access to protected health information that is granted and never exercised
    basis: The smallest access each role needs to deliver care or process a claim
    lostWhen: >-
      Unused access, or access held by people who have changed role or left,
      persists beyond the agreed review window
  - signal: Emergency access events without review
    basis: >-
      The privacy consequence of unreviewed access weighed against the clinical
      need for an override that always works
    lostWhen: >-
      Emergency access events are not reviewed by a named person inside the
      agreed period
  - signal: Unreconciled interface messages
    basis: >-
      The clinical consequence of a missing, duplicated or altered order,
      result or allergy record
    lostWhen: >-
      Differences between sending and receiving systems remain unexplained
      beyond the agreed window
faqs:
  - q: Is the updated HIPAA Security Rule in force?
    a: >-
      No. The update is a notice of proposed rulemaking published in the
      Federal Register on 6 January 2025, with comments due by 7 March 2025. No
      final rule had been published at the date of this review, and the Unified
      Agenda entry lists final action as 07/2027 under Long-Term Actions. The
      existing Security Rule remains the enforceable text. This is a statement
      of published fact and not legal advice.
  - q: Is a successful backup job evidence that a clinical system can be recovered?
    a: >-
      It is evidence that a copy was written. Recovery evidence is a timed
      restore of that copy into an environment that is known to be clean,
      followed by confirmation that the application, its interfaces and its
      access controls work. Under ransomware conditions the usable recovery
      point is earlier than the moment of discovery, so the age of the last
      clean copy matters as much as the time taken to restore it.
  - q: Does Xyvionix give regulatory or clinical advice?
    a: >-
      No. Xyvionix is not a law firm and does not give legal, regulatory or
      clinical advice. It states published facts with their dates, describes
      the evidence an expectation implies, and holds that evidence current.
      Interpretation of the rules remains with the organisation and its
      advisers.
sources:
  - title: 'Federal Register: HIPAA Security Rule notice of proposed rulemaking, 6 January 2025'
    url: 'https://www.govinfo.gov/content/pkg/FR-2025-01-06/pdf/2024-30983.pdf'
  - title: 'Unified Agenda: RIN 0945-AA22, HIPAA Security Rule'
    url: 'https://www.reginfo.gov/public/do/eAgendaViewRule?pubId=202510&RIN=0945-AA22'
  - title: 'HHS Office for Civil Rights: ransomware investigation settlements'
    url: 'https://www.hhs.gov/press-room/ocr-settles-four-ransomware-investigations.html'
  - title: 'HHS Office for Civil Rights: Change Healthcare cybersecurity incident frequently asked questions'
    url: 'https://www.hhs.gov/hipaa/for-professionals/special-topics/change-healthcare-cybersecurity-incident-frequently-asked-questions/index.html'
  - title: 'AWS: disaster recovery options in the cloud'
    url: 'https://docs.aws.amazon.com/whitepapers/latest/disaster-recovery-workloads-on-aws/disaster-recovery-options-in-the-cloud.html'
  - title: 'NHS Data Security and Protection Toolkit: 2025-26 version 8'
    url: 'https://www.dsptoolkit.nhs.uk/News/161'
  - title: 'NHS Innovation Service: updated Digital Technology Assessment Criteria form and guidance'
    url: 'https://innovation.nhs.uk/news/updated-nhs-england-digital-technology-assessment-criteria-dtac-form-and-guidance/'
  - title: 'European Commission: NIS2 Directive transposition'
    url: 'https://digital-strategy.ec.europa.eu/en/policies/nis-transposition'
  - title: 'European Commission: European Health Data Space Regulation'
    url: 'https://health.ec.europa.eu/ehealth-digital-health-and-care/european-health-data-space-regulation-ehds_en'
  - title: 'Joint Commission and Coalition for Health AI: guidance on responsible use of AI in healthcare'
    url: 'https://www.chai.org/news/joint-commission-and-coalition-for-health-ai-chai-release-initial-guidance'
publishedDate: '2026-09-27'
modifiedDate: '2026-09-27'
lastReviewed: '2026-09-27'
reviewCadence: 90
freshnessCritical: true
owner: Xyvionix Research
draft: false
noindex: false
---

## Operational risk where care depends on the system

In most sectors a system outage is measured in lost revenue. In healthcare it is measured first in what a clinician could not see or do. An order that cannot be placed, a result that does not arrive and an allergy that is missing from the record are clinical events before they are technology events.

That changes who sets the threshold. The tolerance for losing a medication, laboratory or imaging system belongs to the clinical owner of the service, who knows how long paper procedures remain safe. A recovery objective chosen by the technology team and never agreed with that owner is a figure, not a threshold.

The estate is also wider than the organisation. The ransomware attack on Change Healthcare in February 2024, on which the HHS Office for Civil Rights maintains a set of questions and answers, showed that a third party outside the hospital can interrupt claims and payment for organisations that were never themselves attacked. A dependency map that stops at the hosted clinical systems omits those services.

Evidence in this sector expires for ordinary reasons. A new interface is built for a new clinic. A department adopts a hosted application. A supplier moves its product to a different platform. None of these is an incident, and each leaves the last risk analysis, access review and recovery test describing an estate that no longer exists.

## Reliability and recovery under ransomware conditions

Recovery in healthcare has to be proven against the hardest case, which is an attacker who has been present for some time and has reached the backups, the identity system and the management tooling.

Three facts shape the proof. First, replication copies corruption. AWS states in its disaster recovery guidance that the recovery point for data corruption or deletion is always before the point at which the event was discovered. The usable copy is older than the plan assumes, by a gap set by detection time. Second, a protected copy is a configuration. Immutability settings can be weakened by a later change, so they need the same checking as any other control. Third, the restore has to land somewhere clean. Restoring a clinical system into an environment whose identity service is still compromised returns the system to the attacker.

The evidence that answers these is a timed restoration: a named system, restored from a protected copy into a clean environment, with the duration measured and the result confirmed by the people who use it. Backup job status does not provide this. The method is described in [Disaster Recovery Assurance](/disaster-recovery-assurance), and a first exercise is scoped in [Untested Disaster Recovery](/untested-disaster-recovery).

## Identity and access to protected health information

Access in a care setting is designed to be generous at the point of need. Clinicians move between wards and sites, temporary and rotating staff arrive and leave on short cycles, workstations are shared, and an emergency override exists because a locked record can harm a patient. Each of these is reasonable. Together they produce an access position that drifts faster than a periodic review can follow.

The assured question is whether the people who can reach protected health information today are those whose current role requires it. Three comparisons answer it:

- **Granted against exercised.** Access that has not been used over the measurement window is standing exposure with no clinical benefit.
- **Role against record.** A person who has moved department or left the organisation should not appear in the access list of the system they used before.
- **Override against review.** Emergency access is a control only if each use is examined afterwards by someone with the authority to question it.

Interface credentials belong in the same comparison. An integration engine often holds broader read access to the record than any clinician.

The mechanism is covered in [Identity Exposure Assurance](/identity-exposure-assurance), and the pattern of access that outlives its purpose in [Identity Access Drift](/identity-access-drift).

## Data integrity across interfaces

A patient record is assembled from many systems. Orders, results, medication, imaging reports and demographics travel between them as messages, and each interface carries a mapping that somebody wrote at a point in time.

Integrity is lost at these joins without any system reporting a fault. A code set is updated in the laboratory system and not in the receiving record. A unit of measure changes at the source. Two patients are matched to one identifier. A queue stalls and results arrive late or not at all. The sending system records a successful send and the receiving system records nothing, so neither raises an alert.

The proof is reconciliation between the two ends: that what was sent was received, once, with its content intact and inside the time the clinical process expects. This is held per interface, because an aggregate figure will hide the one interface that carries allergy updates.

The cluster is described in [Data Assurance](/data-assurance), and the late-arriving case in [Data Pipeline Freshness Failure](/data-pipeline-freshness-failure).

## AI in clinical and operational use

AI reaches healthcare through documentation, decision support, imaging and administrative work. The assurance problem is specific: performance shown in a vendor's validation does not establish performance on a given organisation's patients, workflows and data.

The Joint Commission and the Coalition for Health AI released voluntary guidance on the responsible use of AI in healthcare on 17 September 2025. It recommends policies, local validation and monitoring, which places continuing evidence with the organisation that deploys the tool. Local performance monitoring, the currency of clinical sources used for grounding, protected data in prompts and change control for models are covered in depth in [Healthcare AI Assurance](/healthcare-ai-assurance).

## Regulatory and audit context

Xyvionix is not a law firm and gives no legal, regulatory or clinical advice. The facts below are stated with their dates.

| Instrument | Status at September 2026 | Evidence it implies |
|---|---|---|
| HIPAA Security Rule, United States | The existing rule is the enforceable text. An update was published as a notice of proposed rulemaking on 6 January 2025. No final rule has been published, and the Unified Agenda lists final action as 07/2027 under Long-Term Actions | A risk analysis that describes the estate as it stands today |
| Proposed Security Rule update | Proposes, among other things, multi-factor authentication, vulnerability scans at least once every six months, penetration testing at least once every 12 months and written procedures to restore critical systems and data within 72 hours of the loss | A direction of travel. These are proposals, not requirements |
| HHS OCR Risk Analysis Initiative | Focused on the existing requirement for an accurate and thorough risk analysis. Settlements typically carry corrective action plans monitored by OCR for two years | Proof that the analysis is current and was acted on |
| NHS Data Security and Protection Toolkit | The 2025-26 toolkit is version 8, aligned to CAF version 3.4, with a submission deadline of 30 June 2026. It applies to NHS bodies and to external providers including IT suppliers | Controls that remain true between submissions |
| NHS Digital Technology Assessment Criteria | NHS England refreshed the form and guidance. The old form was to be fully replaced by 6 April 2026 | Supplier evidence that still holds after procurement |
| NIS2 Directive, European Union | Lists health among its covered sectors. The Commission referred four member states to the Court of Justice on 8 July 2026 for failing to notify transposition | Obligations that depend on the national law that applies |
| European Health Data Space Regulation | In force since 26 March 2025. The first priority data categories apply from March 2029 | Preparation, not a live obligation |

The toolkit and the assessment criteria are submissions made at a date. The conditions they describe have to stay true between submissions, and a submission cannot show that they did.

The expectations that call for continuing proof are those written as a standing condition. A risk analysis is accurate only while it matches the estate. The ability to restore is proven only by restoring. A monitored corrective action plan is a two-year evidence obligation by design. Where the proposed update names a frequency, it names a minimum interval between tests. The question that matters to a patient is whether the control worked on the day it was needed.

## Technology economics and change

Much of the change calendar in healthcare belongs to suppliers. The record system vendor sets the upgrade schedule, hosted applications change underneath their customers, and connected equipment often stays in service longer than the software it runs is maintained. Each supplier change is a production change, whether or not it passed through the organisation's own approval process.

Maintenance windows are scarce because clinical systems are in use at all hours. Security findings therefore accumulate faster than they can be corrected. Reducing the backlog to the items that carry real exposure, and closing those by re-test, is covered in [Security Remediation Backlog](/security-remediation-backlog).

The economics follow from the same constraint. Mergers leave duplicate systems running side by side, and retired applications are kept alive because they hold records that must remain readable. Each carries cost, credentials and interfaces. Spending that cannot be tied to a system with an owner and a clinical purpose is the first place to look, because an unowned system is usually also an unassured one.

When a threshold is breached, the state moves to At risk and corrective action begins. Xyvionix owns that action through to completion within the access it has been granted and through the organisation's own change and clinical safety processes. Closure is recorded when a re-test shows the condition is gone: the restore completes inside the tolerance, the access is absent from the live system, the interface reconciles.
